Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples